Clinical Trial

Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control

Study acronym: atropine
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-24.
Trial Details
NCT Number NCT06523504
Lead Sponsor Ruihua Wei
Collaborators: Beijing Tongren Hospital
Conditions Myopia
Enrollment 410 participants
Start Date 2024-02-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08